Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | The role of the immune microenvironment in disease progression in multiple myeloma

Felipe Prosper, MD, PhD, University of Navarra, Pamplona, Spain, discusses research into the role of the immune microenvironment in multiple myeloma. Artificial intelligence (AI) and computational programs have been used to identify immune signatures that may be associated with progression from smoldering multiple myeloma (SMM) or monoclonal gammopathy of undetermined significance (MGUS) to active disease. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.